Mativ (NYSE:MATV – Get Free Report) announced its earnings results on Wednesday. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.17), Zacks reports. The business had revenue of $458.60 million for the quarter, compared to the consensus estimate of $472.70 million. Mativ had a positive return on equity of 3.82% and a negative net margin of 2.46%.
Mativ Trading Down 9.1 %
NYSE MATV opened at $6.79 on Friday. The company has a market cap of $368.86 million, a PE ratio of -7.54, a PEG ratio of 1.32 and a beta of 0.66. The company has a current ratio of 2.37, a quick ratio of 1.29 and a debt-to-equity ratio of 1.31. The stock has a 50 day moving average of $10.03 and a 200-day moving average of $13.91. Mativ has a 12 month low of $6.95 and a 12 month high of $19.96.
Mativ Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Friday, March 14th will be given a dividend of $0.10 per share. The ex-dividend date is Friday, March 14th. This represents a $0.40 annualized dividend and a yield of 5.89%. Mativ’s dividend payout ratio (DPR) is presently -44.44%.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Mativ
About Mativ
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Featured Stories
- Five stocks we like better than Mativ
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Gold’s Ascent: Can Miners and ETFs Take Investors to $3,000?
- How to Invest in Biotech Stocks
- Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Receive News & Ratings for Mativ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mativ and related companies with MarketBeat.com's FREE daily email newsletter.